Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
G. Walmsley Graham currently holds 29,500 shares of Akero Therapeutics, Inc. (AKRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, G. Walmsley Graham has been a net buyer of AKRO stock. They have purchased $86.9M and sold $17.4M worth of shares.
G. Walmsley Graham's most recent insider trade was on Jun 18, 2026, when they sold 29,500 shares at $0.00 per share.
G. Walmsley Graham serves as Executive at Akero Therapeutics, Inc. (AKRO). They have executed 35 insider transactions totaling $104.4M over their tenure at the company.
G. Walmsley Graham holds the position of Executive at Akero Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
G. Walmsley Graham has shown a buying trading pattern, with $86.9M in total purchases and $17.4M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by G. Walmsley Graham was on Nov 23, 2020, when they purchased $22.0M worth of OLMA shares. This transaction involved 1,160,000 shares at $19.00 per share.
G. Walmsley Graham currently owns 29,500 shares of Akero Therapeutics, Inc. (AKRO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of G. Walmsley Graham's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. G. Walmsley Graham has 35 Form 4 filings on record as an insider at Akero Therapeutics, Inc..
Set alerts for G. Walmsley Graham and 40,000+ other insiders.